Progress of cyclooxygense-2 inhibitors in treatment of Alzheimer's disease / 中国临床药理学与治疗学

ABSTRACT

Alzheimer's disease (AD) is the most common cause of dementia in the elderly population. The occurrence of dementia correlates with inflammation. Inflammation processes may play a critical role in the pathogenesi s of the degenerative changes and cognitive impairments associated with Alzheime r's disease. Cyclooxygense-2 (COX-2) inhibitors are reported to be e ffective in reducing the risk of developing AD or cognitive impairments. Studies on this field are of important significance in the understanding the pathogenes is and therapeutic measures for AD. This review will discuss the progress in the treatment of Alzheimer's disease by COX-2 inhibitors.